Jentadueto
Jentadueto is a diabetes medication containing Linagliptin + Metformin, available as 2.5/500mg tablets.
- Category
- Diabetes
- Active ingredient
- Linagliptin · Metformin
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 2.5/500mg
You will receive a quality generic equivalent, depending on stock.
Prescription rules on Jentadueto vary by country.
Details
- Conditions
- Type 2 diabetes mellitus
- Therapeutic Class
- Dipeptidyl Peptidase-4 (DPP-4) Inhibitor / Biguanide
- Pharmacological Class
- DPP-4 Inhibitor / Biguanide
- Minor Side Effects
- nausea, diarrhoea, abdominal pain
- Moderate Side Effects
- hypoglycaemia, headache
- Dosage Forms
- Film-coated tablet
- Administration Route
- Oral use
- Prescription Status
- Available without prescription
- Originator
- Boehringer Ingelheim
- Onset Time
- 1–2 weeks
- Duration
- continuous
- Storage Instructions
- Store below 30°C.
- Drug Interactions
- iodinated contrast media
- Age Restrictions
- Not for children.
What you will receive
Jentadueto is the originator brand name, made by Boehringer Ingelheim. We use it here to identify the medicine only; we are not affiliated with Boehringer Ingelheim and do not ship the original Jentadueto.
- You receive a generic equivalent: the same active ingredient (Linagliptin / Metformin) at the same dose, mostly recognised Indian branded generics from vetted manufacturers.
- The exact brand supplied depends on what is in stock at the dispatching warehouse.
- A regulated generic matches the original ingredient for ingredient by legal standard.